Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 10:19pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
Enter symbol(s):
Market:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
|
Alphabetical List
MannKind Corp. (MNKD)
At 5:00AM SGT:
9.20 USD
0.00 (0.00%)
MORE ON MNKD
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
MannKind Corporation
(NGM:MNKD) Delayed quote data
Last Trade:
9.20 USD
Trade Time:
5:00AM SGT
Change:
0.00 (0.00%)
Prev Close:
9.20
Open:
N/A
Bid:
9.01
x 100
Ask:
9.33
x 900
1y Target Est:
12.75
Day's Range:
N/A - N/A
52wk Range:
2.00 - 12.30
Volume:
0
Avg Vol
(3m)
:
2,326,640
Market Cap:
1.04B
P/E
(ttm)
:
N/A
EPS
(ttm)
:
-2.35
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Use Y! Toolbar to track stocks
Add MNKD to Portfolio
Download Data
HEADLINES
5 Superball Stocks
at Motley Fool
(Mon, Feb 8)
MannKind to Present at the 12th Annual BIO CEO & Investor Conference
Business Wire
(Wed, Feb 3)
MannKind Cuts Costs, Narrows Loss
Zacks.com
(Wed, Feb 3)
Ground Floor -- Going Up!
at Motley Fool
(Wed, Feb 3)
2-Star Stocks Poised to Plunge: MannKind?
at Motley Fool
(Tue, Feb 2)
New Star Analyst Rankings for MannKind Corporation
StarMine
(Tue, Feb 2)
MannKind Corporation Q4 2009 Earnings Call Transcript
at Seeking Alpha
(Tue, Feb 2)
[video] Tupperware Parties On Wall Street
at Forbes.com
(Tue, Feb 2)
UPDATE - MannKind says in new partnership talks on Afrezza
at Reuters
(Tue, Feb 2)
Earnings roundup: Exxon Mobil, Moog
AP
(Tue, Feb 2)
MannKind loss narrows on lower costs
AP
(Tue, Feb 2)
More Headlines for MNKD...
ANALYST
EPS Est (next year)
(Dec-09)
:
-1.94
EPS Est (in 2 years)
(Dec-10)
:
-0.98
Avg Rec (current)*:
2.7
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diseases, such as diabetes and cancer.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
Latest News
Singapore Indices